PARP1 and severe acute respiratory syndrome: No significant differences in mRNA levels of other validated miRNA-223-3p targets with pro-inflammatory activity, such as MEF2C and PARP-1 (56) (Fig. 6), were observed, supporting that miRNA-223-3p regulates specific targets in the context of SARS-CoV infection.